Knight Therapeutics | GUD - Current Assets


Knight Therapeutics reported CAD394.84M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Acasti Pharma USD 17.3M 3.22M Sep/2025
Akebia Therapeutics USD 252.96M 5.38M Dec/2025
Alaunos Therapeutics USD 2.68M 1.05M Sep/2025
Aurora Cannabis CAD 445.84M 22M Dec/2025
Avita Medical AUD 35.49M 760K Dec/2025
Canopy Growth CAD 524.67M 78.85M Dec/2025
Cronos Group USD 944.09M 21.94M Dec/2025
Dianthus Therapeutics USD 409.44M 4.39M Dec/2025
Ionis Pharmaceuticals USD 2.99B 471.01M Dec/2025
IQVIA Holdings USD 6.25B 270M Dec/2025
Knight Therapeutics CAD 394.84M 5.86M Dec/2025
Moderna USD 6.54B 54M Dec/2025
Omeros USD 69.65M 26.53M Jun/2025
Organigram Holdings CAD 256.54M 28.35M Dec/2025
Organon & Co USD 4.7B 82M Sep/2025
Revvity USD 2.24B 95.96M Dec/2025
Tectonic Therapeutic USD 257.36M 15.88M Dec/2025
Tilray USD 729.32M 28.18M Sep/2025
Viatris USD 9.79B 162.2M Dec/2025
Xeris Pharmaceuticals USD 240.31M 16.3M Dec/2025